Lymphoid Diseases

Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes.

These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control.

Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes.

These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control.

Mature B-cell

Leukemia B-cell disorders are lymphoid diseases. They are a clonal expansion of the various stages of B lymphocytes in bone marrow, blood or other tissues.

Multiple Myeloma

Multiple myeloma is a cancer of plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. The immune system is made up of several types of cells that work together to fight infections and other diseases.

Non-Hodgkin Lymphoma (NHL)

Non-Hodgkin lymphoma (also known as non-Hodgkin’s lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system.

Chronic Lymphocytic Leukemia (CLL)

Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. It’s a type of cancer that starts in cells that become certain white blood cells (called lymphocytes) in the bone marrow. The cancer (leukemia) cells start in the bone marrow but then go into the blood.

EXPLORE OUR SOLUTIONS ⟶

Reference: Blood Journal / bloodjournal.org

Mature T-cell

Mature T-cell lymphoma is a rare type of cancer that develops when T-cells, which help fight infection and protect your immune system, begin to divide rapidly and uncontrollably.

Adult T-cell Leukemia/Lymphoma

This T-cell lymphoma is caused by infection with a virus called HTLV-1. It is rare in the United States, and much more common in Japan, the Caribbean, and parts of Africa – where infection with HTLV-1 is more common. It can affect the bone marrow (where new blood cells are made), lymph nodes, spleen, liver, skin, and other organs.

EXPLORE OUR SOLUTIONS ⟶

Reference: Blood Journal / bloodjournal.org

Hematologic Malignancy Research and Testing Menu

BROWSE OUR HEMATOLOGICAL TESTING MENU ⟶

Hematologic Malignancy Research & Testing Menu

BROWSE OUR HEMATOLOGICAL TESTING MENU ⟶

LYMPHOID & MYELOID

EU Notified Body (BSI Netherlands) and the EMA Grant Approval of the LeukoStrat® CDx FLT3 Mutation Assay for VANFLYTA® Therapy in the EU and EEA

wmm2024-10-08T03:14:44-07:00October 8th, 2024|2024 Press Releases, Press Releases|

Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing

Invivoscribe Marketing2024-03-26T13:55:01-07:00March 20th, 2024|2024 Publications, Featured Publications, Publications|

ALL RELATED ARTICLES ⟶

LYMPHOID & MYELOID

EU Notified Body (BSI Netherlands) and the EMA Grant Approval of the LeukoStrat® CDx FLT3 Mutation Assay for VANFLYTA® Therapy in the EU and EEA

wmm2024-10-08T03:14:44-07:00October 8th, 2024|2024 Press Releases, Press Releases|

Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing

Invivoscribe Marketing2024-03-26T13:55:01-07:00March 20th, 2024|2024 Publications, Featured Publications, Publications|

ALL RELATED ARTICLES ⟶

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

CE-IVD

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

CE-IVD

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing

Evaluation of Next-Generation Sequencing Versus Next-Generation Flow Cytometry for Minimal Residual Disease Detection in Chinese Patients with Multiple Myeloma

Lymphoma

Myeloma

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

Lymphoid Diseases

Lymphoid Diseases

Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes.

These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control.

Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes.

These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control.

Mature B-cell

Reference: Blood Journal / bloodjournal.org

Mature T-cell

Reference: Blood Journal / bloodjournal.org

Hematologic Malignancy Research and Testing Menu

Hematologic Malignancy Research & Testing Menu

LYMPHOID & MYELOID

Related Articles

LYMPHOID & MYELOID

Related Articles

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.